Onco-Innovations Announces U.S. Listing on the OTCQB Market
Onco-Innovations (CSE:ONCO)(OTCQB:ONNVF)(Frankfurt: W1H) has announced the commencement of trading its common shares on the OTCQB marketplace under the symbol 'ONNVF'. The company will maintain its listing on the Canadian Securities Exchange under 'ONCO'.
This strategic move to the OTCQB Venture Market is designed to enhance the company's visibility and accessibility to U.S. investors, potentially expanding its shareholder base. CEO Thomas O'Shaughnessy emphasized that this listing represents a significant milestone for the company's growth strategy in driving oncology innovation.
The OTCQB Venture Market provides a platform for early-stage and growth companies to increase their U.S. market presence, with real-time quotes and market information available at otcmarkets.com.
Onco-Innovations (CSE:ONCO)(OTCQB:ONNVF)(Francoforte: W1H) ha annunciato l'inizio della negoziazione delle sue azioni ordinarie sul mercato OTCQB con il simbolo 'ONNVF'. L'azienda manterrà la sua quotazione sulla Canadian Securities Exchange con il simbolo 'ONCO'.
Questa mossa strategica verso il mercato OTCQB Venture è progettata per migliorare la visibilità e l'accessibilità dell'azienda per gli investitori statunitensi, espandendo potenzialmente la sua base di azionisti. Il CEO Thomas O'Shaughnessy ha sottolineato che questa quotazione rappresenta un traguardo significativo per la strategia di crescita dell'azienda nel guidare l'innovazione in oncologia.
Il mercato OTCQB Venture offre una piattaforma per le aziende in fase iniziale e in crescita per aumentare la loro presenza nel mercato statunitense, con quotazioni in tempo reale e informazioni di mercato disponibili su otcmarkets.com.
Onco-Innovations (CSE:ONCO)(OTCQB:ONNVF)(Fráncfort: W1H) ha anunciado el inicio de la negociación de sus acciones comunes en el mercado OTCQB bajo el símbolo 'ONNVF'. La empresa mantendrá su cotización en la Canadian Securities Exchange bajo 'ONCO'.
Este movimiento estratégico hacia el mercado OTCQB Venture está diseñado para mejorar la visibilidad y accesibilidad de la empresa para los inversores estadounidenses, potencialmente expandiendo su base de accionistas. El CEO Thomas O'Shaughnessy enfatizó que esta cotización representa un hito significativo para la estrategia de crecimiento de la empresa en la promoción de la innovación en oncología.
El mercado OTCQB Venture proporciona una plataforma para empresas en etapas tempranas y en crecimiento para aumentar su presencia en el mercado estadounidense, con cotizaciones en tiempo real e información de mercado disponible en otcmarkets.com.
Onco-Innovations (CSE:ONCO)(OTCQB:ONNVF)(프랑크푸르트: W1H)는 'ONNVF' 기호로 OTCQB 시장에서 보통주 거래를 시작한다고 발표했습니다. 회사는 'ONCO'라는 기호로 캐나다 증권 거래소에 상장된 상태를 유지할 것입니다.
OTCQB 벤처 시장으로의 이 전략적 이동은 미국 투자자들에게 회사의 가시성과 접근성을 높여 잠재적으로 주주 기반을 확장하기 위해 설계되었습니다. CEO인 Thomas O'Shaughnessy는 이번 상장이 회사의 성장 전략에서 중요한 이정표를 나타낸다고 강조했습니다. 이는 종양학 혁신을 추진하는 데 기여할 것입니다.
OTCQB 벤처 시장은 초기 단계 및 성장하는 기업들이 미국 시장에서의 존재감을 높일 수 있는 플랫폼을 제공하며, 실시간 시세 및 시장 정보는 otcmarkets.com에서 확인할 수 있습니다.
Onco-Innovations (CSE:ONCO)(OTCQB:ONNVF)(Francfort: W1H) a annoncé le début de la négociation de ses actions ordinaires sur le marché OTCQB sous le symbole 'ONNVF'. L'entreprise conservera son inscription à la Canadian Securities Exchange sous 'ONCO'.
Ce mouvement stratégique vers le marché OTCQB Venture est conçu pour améliorer la visibilité et l'accessibilité de l'entreprise pour les investisseurs américains, élargissant potentiellement sa base d'actionnaires. Le PDG Thomas O'Shaughnessy a souligné que cette inscription représente une étape importante pour la stratégie de croissance de l'entreprise dans la promotion de l'innovation en oncologie.
Le marché OTCQB Venture offre une plateforme pour les entreprises en phase de démarrage et en croissance afin d'augmenter leur présence sur le marché américain, avec des cotations en temps réel et des informations de marché disponibles sur otcmarkets.com.
Onco-Innovations (CSE:ONCO)(OTCQB:ONNVF)(Frankfurt: W1H) hat den Beginn des Handels seiner Stammaktien auf dem OTCQB-Markt unter dem Symbol 'ONNVF' bekannt gegeben. Das Unternehmen wird seine Listung an der Canadian Securities Exchange unter 'ONCO' beibehalten.
Dieser strategische Schritt zum OTCQB Venture Market soll die Sichtbarkeit und Zugänglichkeit des Unternehmens für US-Investoren erhöhen und möglicherweise die Aktionärsbasis erweitern. CEO Thomas O'Shaughnessy betonte, dass diese Listung einen bedeutenden Meilenstein für die Wachstumsstrategie des Unternehmens darstellt, um Innovationen in der Onkologie voranzutreiben.
Der OTCQB Venture Market bietet eine Plattform für Unternehmen in der Frühphase und im Wachstum, um ihre Präsenz auf dem US-Markt zu erhöhen, wobei Echtzeitkurse und Marktdaten unter otcmarkets.com verfügbar sind.
- Expanded market access through OTCQB listing
- Increased visibility to U.S. investors
- Potential for broader shareholder base
- None.
VANCOUVER, BC / ACCESS Newswire / February 21, 2025 / Onco-Innovations Limited (CSE:ONCO)(OTCQB:ONNVF)(Frankfurt: W1H,WKN: A3EKSZ) ("Onco" or the "Company") is pleased to announce that its common shares have commenced trading on the OTCQB marketplace under the symbol "ONNVF". The Company's shares will continue to trade on the Canadian Securities Exchange under the symbol "ONCO".
The listing on the OTCQB is a step in enhancing the Company's visibility and accessibility for U.S. investors. This milestone is expected to expand Onco-Innovations' visibility in the U.S. investment market.
"This listing marks a significant milestone for Onco-Innovations, allowing us to engage more effectively with U.S. investors and offering us the ability to expand our shareholder base. We are committed to driving innovation in oncology and believe this increased accessibility will support our long-term growth," said Thomas O'Shaughnessy, CEO of the Company.
The OTCQB Venture Market provides an established platform for early-stage and growth companies to enhance their visibility in the U.S. market. Real-time quotes and market information on Onco-Innovations can be found at www.otcmarkets.com.
About Onco-Innovations Limited
Onco-Innovations is a Canadian-based company dedicated to cancer research and treatment, specializing in oncology. Onco's mission is to prevent and cure cancer through pioneering research and innovative solutions. The company has secured an exclusive worldwide license to patented technology that targets solid tumours, setting new standards in cancer treatment. Onco's commitment to excellence and innovation drives it to develop advanced therapies that improve patient outcomes and offer hope in the fight against cancer.
ON BEHALF OF ONCO-INNOVATIONS LIMITED,
"Thomas O'Shaughnessy"
Chief Executive Officer
For more information, please contact:
Thomas O'Shaughnessy
Chief Executive Officer
Tel: + 1 888 261 8055
investors@oncoinnovations.com
The CSE and Information Service Provider have not reviewed and do not accept responsibility for the accuracy or adequacy of this release.
Forward-Looking Statements Caution. This news release contains forward-looking statements, including in relation to and the potential benefits of the Company's shares being posted for trading on the OTCQB, and the Company's prospects and business and plans generally, and other statements that are not historical facts. Forward-looking statements are often identified by terms such as "will", "may", "potential", "should", "anticipate", "expects" and similar expressions. All statements other than statements of historical fact, included in this release are forward-looking statements that involve risks and uncertainties. There can be no assurance that such statements will prove to be accurate and actual results and future events could differ materially from those anticipated in such statements. Important factors that could cause actual results to differ materially from the Company's expectations include the failure to expand the Company's shareholder base or to attract U.S. investment interest, and other risks detailed from time to time in the filings made by the Company with securities regulators. The reader is cautioned that assumptions used in the preparation of any forward-looking information may prove to be incorrect. Events or circumstances may cause actual results to differ materially from those predicted, as a result of numerous known and unknown risks, uncertainties, and other factors, many of which are beyond the control of the Company. The reader is cautioned not to place undue reliance on any forward-looking information. Such information, although considered reasonable by management at the time of preparation, may prove to be incorrect and actual results may differ materially from those anticipated. Forward-looking statements contained in this news release are expressly qualified by this cautionary statement. The forward-looking statements contained in this news release are made as of the date of this news release and the Company will update or revise publicly any of the included forward-looking statements as expressly required by applicable law.
SOURCE: Onco-Innovations Limited
View the original press release on ACCESS Newswire
FAQ
When did Onco-Innovations (ONNVF) begin trading on the OTCQB?
What exchanges does Onco-Innovations (ONNVF) trade on?
What are the benefits of Onco-Innovations' OTCQB listing for investors?
Where can investors find real-time quotes for Onco-Innovations (ONNVF)?
